JP2022539804A5 - - Google Patents
Info
- Publication number
- JP2022539804A5 JP2022539804A5 JP2022500582A JP2022500582A JP2022539804A5 JP 2022539804 A5 JP2022539804 A5 JP 2022539804A5 JP 2022500582 A JP2022500582 A JP 2022500582A JP 2022500582 A JP2022500582 A JP 2022500582A JP 2022539804 A5 JP2022539804 A5 JP 2022539804A5
- Authority
- JP
- Japan
- Prior art keywords
- linker
- compound according
- compound
- agonist
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026009377A JP2026090286A (ja) | 2019-07-08 | 2026-01-23 | 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962871686P | 2019-07-08 | 2019-07-08 | |
| US62/871,686 | 2019-07-08 | ||
| US201962872146P | 2019-07-09 | 2019-07-09 | |
| US62/872,146 | 2019-07-09 | ||
| PCT/US2020/041120 WO2021007277A1 (en) | 2019-07-08 | 2020-07-08 | Compounds and methods for the treatment and prevention of fibrotic disease states and cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026009377A Division JP2026090286A (ja) | 2019-07-08 | 2026-01-23 | 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539804A JP2022539804A (ja) | 2022-09-13 |
| JP2022539804A5 true JP2022539804A5 (cg-RX-API-DMAC7.html) | 2023-07-14 |
| JP7904596B2 JP7904596B2 (ja) | 2026-08-13 |
Family
ID=74114231
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500582A Active JP7904596B2 (ja) | 2019-07-08 | 2020-07-08 | 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法 |
| JP2026009377A Pending JP2026090286A (ja) | 2019-07-08 | 2026-01-23 | 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026009377A Pending JP2026090286A (ja) | 2019-07-08 | 2026-01-23 | 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12397059B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3996715A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7904596B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN114269346A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020310141A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3145908A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021007277A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4337265A4 (en) * | 2021-05-14 | 2026-03-25 | Purdue Research Foundation | TARGETED FOLATE RECEPTOR CONJUGATIONS WITH BRUSH-ON ENZYME-CLEVABLE BINDERS AND METHODS OF USE IN CANCER IMAGING AND TREATMENT |
| CN116947658B (zh) * | 2023-07-28 | 2025-10-28 | 南通华祥医药科技有限公司 | 一种1-氨基-2-甲基-2-丙醇的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060142202A1 (en) | 2000-12-08 | 2006-06-29 | 3M Innovative Properties Company | Compositions and methods for targeted delivery of immune response modifiers |
| DE60234782D1 (de) * | 2001-09-28 | 2010-01-28 | Purdue Research Foundation | Behandlungsverfahren mit liganden-immunogenkonjugaten |
| AU2007216247A1 (en) * | 2006-02-17 | 2007-08-23 | Pfizer Limited | 3 -deazapurine derivatives as TLR7 modulators |
| TW200902018A (en) * | 2007-03-20 | 2009-01-16 | Dainippon Sumitomo Pharma Co | Novel adenine compound |
| CN112587671A (zh) | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| EP3223860A4 (en) | 2014-11-25 | 2018-08-01 | Endocyte, Inc. | Methods of treating cancer by targeting tumor-associated macrophages |
| CN109475558A (zh) * | 2016-05-25 | 2019-03-15 | 普渡研究基金会 | 通过靶向骨髓衍生的抑制细胞而治疗癌症的方法 |
| AU2021305193A1 (en) * | 2020-07-08 | 2023-02-09 | Purdue Research Foundation | Compounds, compositions, and methods for the treatment of fibrotic diseases and cancer |
-
2020
- 2020-07-08 CN CN202080058464.1A patent/CN114269346A/zh active Pending
- 2020-07-08 EP EP20836085.9A patent/EP3996715A4/en active Pending
- 2020-07-08 JP JP2022500582A patent/JP7904596B2/ja active Active
- 2020-07-08 US US17/625,461 patent/US12397059B2/en active Active
- 2020-07-08 CN CN202510532845.3A patent/CN120381528A/zh active Pending
- 2020-07-08 CA CA3145908A patent/CA3145908A1/en active Pending
- 2020-07-08 WO PCT/US2020/041120 patent/WO2021007277A1/en not_active Ceased
- 2020-07-08 AU AU2020310141A patent/AU2020310141A1/en not_active Abandoned
-
2025
- 2025-07-09 US US19/264,776 patent/US20250352652A1/en active Pending
-
2026
- 2026-01-23 JP JP2026009377A patent/JP2026090286A/ja active Pending
- 2026-06-15 AU AU2026204568A patent/AU2026204568A1/en active Pending